Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 1/20 | 0.67 |
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.61 |
| ▸ | ALPI | P09923 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | XIAP | P98170 | 1/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | EGFR | P00533 | 1/20 | 0.53 |
| ▸ | LCK | P06239 | 1/20 | 0.53 |
| ▸ | FYN | P06241 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL738554 | 1.00 | PTPRC (0.67) | PTPRCSLC7A5PTGS1ALPIPKM | |
| SCHEMBL12501710 | 1.00 | PTPRC (0.67) | PTPRCSLC7A5PTGS1ALPIPKM | |
| Hydrochloric Acid SCHEMBL9556543 | 0.98 | PTPRC (0.65) | PTPRCSLC7A5PTGS1ALPIPKM | |
| Hydrochloric Acid SCHEMBL9556546 | 0.98 | PTPRC (0.65) | PTPRCSLC7A5PTGS1ALPIPKM | |
| Butylamine SCHEMBL6354985 | 0.87 | PTPRC (0.53) | PTPRCSLC7A5PTGS1ALPIPKM | |
| SCHEMBL14317337 | 0.86 | PTPRC (0.50) | PTPRCSLC7A5PTPN1 | |
| SCHEMBL2310526 | 0.84 | SLC7A5 (0.83) | PTPRCSLC7A5PTGS1ALPIPKM | |
| SCHEMBL6021374 | 0.83 | MAPK1 (0.66) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL499205 | 0.83 | MAPK1 (0.66) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL215652 | 0.83 | PTPRC (0.56) | PTPRCSLC7A5PTGS1ALPIPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 421 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600699-B2 | Thiosemicarbazates and uses thereof | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-04-14 | — | — | US | claimed |
| US-12351573-B2 | Compounds for use in synthesis of peptidomimetics | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2025-07-08 | — | — | US | claimed |
| CN-119060630-A | Single-component water-based high-temperature-resistant paint with temperature spraying function and preparation method thereof | 河北比尔尼克新材料科技股份有限公司 | 2024-12-03 | — | — | CN | claimed |
| US-20230220007-A1 | SETD7 EPIGENETIC MODULATORS | BIORCHESTRA CO., LTD. (KR) | 2023-07-13 | — | — | US | claimed |
| US-20230111252-A1 | THIOSEMICARBAZATES AND USES THEREOF | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2023-04-13 | — | — | US | claimed |
| US-20220372022-A1 | COMPOUNDS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2022-11-24 | — | — | US | claimed |
| WO-2021209930-A1 | SETD7 EPIGENETIC MODULATORS | BIORCHESTRA CO., LTD. (KR) | 2021-10-21 | — | — | WO | claimed |
| US-20210032304-A1 | FIBROBLAST GROWTH FACTOR ANALOGS AND USES THEREOF | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2021-02-04 | — | — | US | claimed |
| EP-3752174-A1 | FIBROBLAST GROWTH FACTOR ANALOGS AND USES THEREOF | University of Florida Research Foundation, Incorporated (US) | 2020-12-23 | — | — | EP | claimed |
| CN-111936157-A | Fibroblast growth factor analogs and uses thereof | 佛罗里达大学研究基金会 | 2020-11-13 | — | — | CN | claimed |
| US-20140057877-A1 | Therapeutic polyamine compositions and their synthesis | MURPHY MICHAEL A (US) | 2014-02-27 | — | — | US | claimed |
| EP-2673381-A2 | BIOPROBES AND METHODS OF USE THEREOF | The Governing Council Of The University Of Toronto (CA) | 2013-12-18 | — | — | EP | claimed |
| WO-2012109157-A2 | BIOPROBES AND METHODS OF USE THEREOF | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2012-08-16 | — | — | WO | claimed |
| US-20090030181-A1 | Peptides for Inhibiting MDM2 Function | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KP) | 2009-01-29 | — | — | US | claimed |
| JP-2006502081-A | — | — | 2006-01-19 | — | — | JP | claimed |
| WO-2005097820-A1 | PEPTIDES FOR INHIBITING MDM2 FUNCTION | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2005-10-20 | — | — | WO | claimed |
| US-20050085555-A1 | Composition, synthesis and therapeutic applications of polyamines | MURPHY, MICHAEL A. | 2005-04-21 | — | — | US | claimed |
| EP-1465611-A2 | COMPOSITION, SYNTHESIS AND THERAPEUTIC APPLICATIONS OF POLYAMINES | Murphy, Michael A. (US) | 2004-10-13 | — | — | EP | claimed |
| WO-2003051348-A2 | COMPOSITION, SYNTHESIS AND THERAPEUTIC APPLICATIONS OF POLYAMINES | MURPHY MICHAEL A (US) | 2003-06-26 | — | — | WO | claimed |
| US-6307090-B1 | OXALYL ENDCAPPED; CONTAINING A BIVALENT RADICAL OF PHOSPHOTYROSINE OR A PHOSPHOTYROSINE MIMETIC | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2001-10-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12351573-B2 | Compounds for use in synthesis of peptidomimetics | DNPEP, NPEPPS, PAM | PTPRC 2241/4885SLC7A5 1166/4885PTGS1 2925/4885 |
| US-20230220007-A1 | SETD7 EPIGENETIC MODULATORS | SETD7, NSD1, PRMT7 | PTPRC 1221/4885SLC7A5 2865/4885PTGS1 4606/4885 |
| US-20050085555-A1 | Composition, synthesis and therapeutic applications of polyamines | PRDX5, PINK1, ARG2 | PTPRC 437/4885SLC7A5 3319/4885PTGS1 766/4885 |
| US-20230111252-A1 | THIOSEMICARBAZATES AND USES THEREOF | TST, ABAT, AADAC | PTPRC 3286/4885SLC7A5 378/4885PTGS1 4428/4885 |
| US-20220372022-A1 | COMPOUNDS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS | DNPEP, NPEPPS, PAM | PTPRC 2241/4885SLC7A5 1166/4885PTGS1 2925/4885 |
| US-20140057877-A1 | Therapeutic polyamine compositions and their synthesis | MCU, PC, PINK1 | PTPRC 402/4885SLC7A5 3233/4885PTGS1 484/4885 |
| US-12600699-B2 | Thiosemicarbazates and uses thereof | MET, THRB, ABAT | PTPRC 1452/4885SLC7A5 64/4885PTGS1 3489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.